• Structural basis for the DNA-binding activity of the bacterial β-propeller protein YncE.

  Kagawa W, Sagawa T, Niki H, Kurumizaka H.
  Acta Crystallogr D Biol Crystallogr. 2011 Dec;67(Pt 12):1045-53. Epub 2011 Nov 5.

• Direct inhibition of TNF-α promoter activity by Fanconi anemia protein FANCD2.

  Matsushita N, Endo Y, Sato K, Kurumizaka H, Yamashita T, Takata M, Yanagi S.
  LoS One. 2011;6(8):e23324. Epub 2011 Aug 31.

• Comprehensive structural analysis of mutant nucleosomes containing lysine to glutamine (KQ) substitutions in the H3 and H4 histone-fold domains.

  Iwasaki W, Tachiwana H, Kawaguchi K, Shibata T, Kagawa W, Kurumizaka H.
  Biochemistry 2011 Sep 13;50(36):7822-32.

• Crystal structure of the human centromeric nucleosome containing CENP-A.

  Tachiwana H, Kagawa W, Shiga T, Osakabe A, Miya Y, Saito K, Hayashi-Takanaka Y, Oda T, Sato M, Park S, Hiroshi Kimura, Kurumizaka H.
  Nature, 2011 July 10, 476(7359):232-5.

  本論文は、新着論文レビューに掲載されました。
• Purification of the human SMN-GEMIN2 complex and assessment of its stimulation of RAD51-mediated DNA recombnation reactions.

  Takaku M, Tsujita T, Horikoshi N, Takizawa Y, Qing Y, Hirota K, Ikura T,Takeda S, Kurumizaka H.
  Biochemistry. 2011 Aug 16;50(32):6797-805.

• Structures of human nucleosomes containing major histone H3 variants.

  Tachiwana H, Osakabe A, Shiga T, Miya Y, Kimura H, Kagawa W, Kurumizaka H.
  Acta Crystallogr D Biol Crystallogr, Vol.67 pp.578-583.(2011)

• Tracking epigenetic histone modifications in single cells using Fab-based live endogenous modification labeling.

  Hayashi-Takanaka Y, Yamagata K, Wakayama T, Stasevich T.J, Mikawa T, Kainuma T, Tsurimoto T, Tachibana M, Shinkai Y, Kurumizaka H, Nozaki N, Kimura H.
  Nucleic Acids Res. 2011 Aug;39(15):6475-88.

• Vital roles of the second DNA binding site of Rad52 in yeast homologous recombination.

  Arai N, Kagawa W, Saito K, Shingu Y, Mikawa T, Kurumizaka H, Shibata T.
  J Biol Chem, 2011 May 20;286(20):17607-17.

• Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway.

  Yamamoto N.K, Kobayashi S, Tsuda M, Kurumizaka H, Takata M, Kono K, Jiricny J, Hirota K.
  Proc Natl Acad Sci USA, 2011 Apr 19;108(16):6492-6.

• Biochemical analysis of the human Ena/Vasp-family proteins, MENA, VASP, and EVL, in homologous recombination.

  Takaku M, Ueno H, Kurumizaka H.
  J Biochem, 2011 Jun;149(6):721-9.

• Halenaquinone a chemical compound that specifically inhibits the secondary DNA binding of RAD51.

  Takaku M, Kainuma T, Ishida-Takaku T, Ishigami S, Suzuki H, Tashiro S, van Soest, R.W.M, Nakao Y, Kurumizaka H.
  Genes Cells. 2011 Apr;16(4):427-36

• Structural and biochemical analyses of the human PAD4 variant encoded by a functional haplotype gene.

  Horikoshi N, Tachiwana H, Saito K, Osakabe A, Sato M, Yamada M, Akashi S, Nishimura Y, Kagawa W, Kurumizaka H.
  Acta Crystallogr D Biol Crystallogr. 2011 Feb;67(Pt 2):112-8.